Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pyrimidines as PLK inhibitors

Pyrimidines as PLK inhibitors

US Patent 7241769 · Granted Jul 10, 2007

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Substituted 1H-pyrazolo[4,3-c]pyridines and derivatives as EGFR inhibitors2024
Substituted 1H-pyrazolo[4,3-c]pyridines and derivatives as EGFR inhibitors2024
Substituted 1H-pyrazolo[4,3-c]pyridines and derivatives as EGFR inhibitors2024
Heterocyclic compounds capable of activating STING2024
Annulated 2-amino-3-cyano thiophenes and derivatives for the treatment of cancer2024
Benzylamino substituted pyridopyrimidinones and derivatives as SOS1 inhibitors2023
Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors2023
Tosylacetate based compounds and derivatives thereof as PHGDH inhibitors2022
[1,6]naphthyridine compounds and derivatives as CDK8/CDK19 inhibitors2022
Phenylpyrazolylacetamide compounds and derivatives as CDK8/CDK19 inhibitors2022
Benzimidazole compounds and derivatives as EGFR inhibitors2021
Triazolopyrazine2021